Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial

  • Fabrizio De Benedetti
  • , Hermine Brunner
  • , Nicolino Ruperto
  • , Andrew Kenwright
  • , Clare Devlin
  • , Inmaculada Calvo
  • , Ruben Cuttica
  • , Angelo Ravelli
  • , Rayfel Schneider
  • , Despina Eleftheriou
  • , Carine H. Wouters
  • , Ricardo Xavier
  • , Lawrence S. Zemel
  • , Eileen M. Baildam
  • , Ruben Burgos-Vargas
  • , Pavla Dolezalova
  • , Stella Maris Garay
  • , Rik Joos
  • , Alexei Grom
  • , Nico Wulffraat
  • Zbigniew Zuber, Francesco Zulian, Alberto Martini, Daniel Lovell

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)4047-4047
JournalArthritis and Rheumatism
Volume63
Issue number12
Publication statusPublished - Dec 2011

Cite this